The protein expression profile of ACE2 in human tissues
Open accessPublished version of a preprint
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
The novel SARS‐coronavirus 2 (SARS‐CoV‐2) poses a global challenge on healthcare and society. For understanding the susceptibility for SARS‐CoV‐2 infection, the cell type‐specific expression of the host cell surface receptor is necessary. The key protein suggested to be involved in host cell entry is angiotensin I converting enzyme 2 (ACE2). Here, we report the expression pattern of ACE2 across > 150 different cell types corresponding to all major human tissues and organs based on stringent immunohistochemical analysis. The results were compared with several datasets both on the mRNA and protein level. ACE2 expression was mainly observed in enterocytes, renal tubules, gallbladder, cardiomyocytes, male reproductive cells, placental trophoblasts, ductal cells, eye, and vasculature. In the respiratory system, the expression was limited, with no or only low expression in a subset of cells in a few individuals, observed by one antibody only. Our data constitute an important resource for further studies on SARS‐CoV‐2 host cell entry, in order to understand the biology of the disease and to aid in the development of effective treatments to the viral infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which in a recent large-scale study based on antibody-based proteomics was shown to be mainly localized to the digestive system, kidney, heart, testis, placenta, eye and upper respiratory epithelia148.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [148]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the heart, ACE2 has been reported to be expressed on cardiomyocytes, pericytes (cells present along the walls of capillaries), and macrophages with lower expression on fibroblasts and endothelial cells.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 2×
“…of ACE2, including gastrointestinal symptoms (Guan et al , 2020), renal failure (preprint: Cheng et al , 2020; preprint: Wang et al , 2020a), cardiac injury (Huang et al , 2020; preprint: Hui et al , 2020a; Zheng et al , 2020), and effects on male gonadal function (preprint: Ma et al , 2020).”
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · cited 1×
“Recent studies suggest that also SARS-CoV-2 employs ACE2 and cellular proteases for host cell entry, including TMPRSS2, CTSB, and CTSL (Hoffmann et al , 2020) and that the affinity between ACE2 and the SARS-CoV-2 S protein interaction is high enough for human transmission (Shang et al , 2020).”
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Self-citationIntegrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174 · cited 1×
“0 (https://satijalab.org/seurat/9) (Butler et al , 2018) in R (CRAN).”
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“The original report of ACE2 protein expression showed positivity in most tissue and cell types examined, including AT2 cells (Hamming et al , 2004).”
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661 · cited 1×
“Recent studies suggest that also SARS-CoV-2 employs ACE2 and cellular proteases for host cell entry, including TMPRSS2, CTSB, and CTSL (Hoffmann et al , 2020) and that the affinity between ACE2 and the SARS-CoV-2 S protein interaction is high enough for human transmission (Shang et al , 2020).”
COVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970 · cited 1×
“…of ACE2, including gastrointestinal symptoms (Guan et al , 2020), renal failure (preprint: Cheng et al , 2020; preprint: Wang et al , 2020a), cardiac injury (Huang et al , 2020; preprint: Hui et al , 2020a; Zheng et al , 2020), and effects on male gonadal function (preprint: Ma et al , 2020).”
Kidney disease is associated with in-hospital death of patients with COVID-19
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.005 · Cited by 2,941
A subcellular map of the human proteome
Thul, P. J., Åkesson, L., Wiking, M., Mahdessian, D., Geladaki, A., Ait Blal, H., Alm, T., Asplund, A., Björk, L., Breckels, L. M., et al. (2017) · Science · doi:10.1126/science.aal3321 · Cited by 2,813
Self-citation
Cited by
Items 201–300 of 1,000
MECHANISM OF SARS-COV-2 INVASION INTO THE LIVER AND HEPATIC INJURY IN PATIENTS WITH COVID-19
Zhang, X., Yu, Y., Zhang, C., Zhao, L., Wang, H., Wang, G., & Yang, M. (2022) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2022.003 · Cited by 44
Saso, W., Yamasaki, M., Nakakita, S., Fukushi, S., Tsuchimoto, K., Watanabe, N., Sriwilaijaroen, N., Kanie, O., Muramatsu, M., Takahashi, Y., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010590 · Cited by 42
“Interestingly, ACE2 expression in the respiratory tissue is limited as compare to other organs such as the heart or kidney [45,46].”
BackgroundSex hormones in SARS-CoV-2 susceptibility: key players or confounders?
Lott, N., Gebhard, C. E., Bengs, S., Haider, A., Kuster, G. M., Regitz‐Zagrosek, V., & Gebhard, C. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00780-6 · Cited by 43
Omenn, G. S., Lane, L., Overall, C. M., Cristea, I. M., Corrales, F. J., Lindskog, C., Paik, Y., Eyk, J. E. V., Liu, S., Pennington, S. R., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00485 · Cited by 41
Self-citationSherman, E. J., & Emmer, B. T. (2021) · Scientific Reports · doi:10.1038/s41598-021-95308-9 · Cited by 41
SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?
Lui, K. O., Ma, Z., & Dimmeler, S. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad191 · Cited by 42
Genetically modified mouse models to help fight COVID-19
Gurumurthy, C. B., Quadros, R. M., Richardson, G. P., Poluektova, L. Y., Mansour, S. L., & Ohtsuka, M. (2020) · Nature Protocols · doi:10.1038/s41596-020-00403-2 · Cited by 41
Sahai, A., Bhandari, R., Koupenova, M., Freedman, J. E., Godwin, M., McIntyre, T. M., Chung, M. K., Iskandar, J., Kamran, H., Aggarwal, A., et al. (2020) · doi:10.21203/rs.3.rs-119031/v1 · Cited by 41
Intestinal barrier dysfunction as a key driver of severe COVID-19
Tsounis, E. P., Triantos, C. K., Konstantakis, C., Marangos, M. N., & Assimakopoulos, S. F. (2023) · World Journal of Virology · doi:10.5501/wjv.v12.i2.68 · Cited by 42
Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses
Owens, K. L., Esmaeili, S., & Schiffer, J. T. (2024) · JCI Insight · doi:10.1172/jci.insight.176286 · Cited by 42
“Previous models of SARS-CoV-2 infection in the nasal compartment have used an initial value of 1 × 10 7 to 1 × 10 8 susceptible cells, based on estimates that 2%–20% of epithelial cells in the URT display the angiotensin-converting enzyme 2 (ACE2) receptor (66, 67).”
BackgroundRangon, C.-M., Krantic, S. M., Moyse, E., & Fougère, B. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200273 · Cited by 42
“ACE2 is ubiquitously expressed in numerous other tissues, encompassing about 150 different cell types [34].”
BackgroundMultimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins
Bouwman, K. M., Tomris, I., Turner, H. L., van der Woude, R., Shamorkina, T. M., Bosman, G. P., Rockx, B., Herfst, S., Snijder, J., Haagmans, B. L., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009282 · Cited by 40
“Some studies have been performed with anti-ACE2 antibodies, but these stainings appear not to correlate with infection patterns [40,41].”
BackgroundSingle-cell RNA sequencing of SARS–CoV-2 cell entry factors in the preconceptional human endometrium
Vilella, F., Wang, W., Moreno, I., Rosón, B., Quake, S. R., & Simón, C. (2021) · Human Reproduction · doi:10.1093/humrep/deab183 · Cited by 40
“Interestingly, low expression of ACE2 in respiratory and olfactory cells supports the possibility that the virus requires cofactors to facilitate viral entry (Hikmet et al., 2020).”
BackgroundKalejaiye, T. D., Bhattacharya, R., Burt, M. A., Travieso, T., Okafor, A. E., Mou, X., Blasi, M., & Musah, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.855340 · Cited by 40
“Studies have shown that some cells with little to no ACE2 expression can still be infected with SARS-CoV-2 (Hikmet et al., 2020; Singh et al., 2020), suggesting that other class of receptors might facilitate viral infection in ACE2-deficient cell types.”
BackgroundSARS-CoV-2 and pancreas: a potential pathological interaction?
Geravandi, S., Mahmoudi-Aznaveh, A., Azizi, Z., Maedler, K., & Ardestani, A. D. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.07.004 · Cited by 39
“We apologize that we had to focus only on islet studies and were unable to cite many primary Trends in Endocrino references due to strict limitations of 15 references in this format.”
InfluentialSuresh, V., Parida, D., Minz, A. P., Sethi, M., Sahoo, B. S., & Senapati, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.579330 · Cited by 40
“Prior studies have reported high expression of ACE2 in human gut tissues (Hamming et al., 2004; Hikmet et al., 2020).”
BackgroundDeterminants of expression of SARS‐CoV‐2 entry‐related genes in upper and lower airways
Aliee, H., Massip, F., Qi, C., de Biase, M. S., van Nijnatten, J., Kersten, E. T. G., Kermani, N. Z., Khuder, B., Vonk, J. M., Vermeulen, R. C. H., et al. (2021) · Allergy · doi:10.1111/all.15152 · Cited by 40
The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection
Maiuolo, J., Mollace, R., Gliozzi, M., Musolino, V., Carresi, C., Paone, S., Scicchitano, M., Macrì, R., Nucera, S., Bosco, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239309 · Cited by 39
“In contrast, the expression of ACE2 is more specific and is limited in the heart, kidney, endothelial cells, and microvasculature [46,47].”
BackgroundEffect of aspirin on short-term outcomes in hospitalized patients with COVID-19
Sahai, A., Bhandari, R., Godwin, M., McIntyre, T. M., Chung, M. K., Iskandar, J., Kamran, H., Hariri, E. H., Aggarwal, A., Burton, R., et al. (2021) · Vascular Medicine · doi:10.1177/1358863x211012754 · Cited by 38
Zhang, F., Li, W., Feng, J., da Silva, S. R., Ju, E., Zhang, H., Chang, Y., Moore, P. S., Guo, H., & Gao, S. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27244 · Cited by 39
Napolitano, F., Xu, X., & Gao, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab456 · Cited by 42
“Many transcriptomics studies were conducted to elucidate infection risk and mechanisms by evaluating the expression of angiotensinconverting enzyme 2 (ACE2) in different organs, such as lungs, heart, kidneys, intestines, brain and testicles [7, 67, 120, 168, 181, 182].”
Zarkoob, H., Allué‐Guardia, A., Chen, Y., Garcia‐Vilanova, A., Jung, O., Coon, S. L., Song, M. J., Park, J., Oladunni, F. S., Miller, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03753-7 · Cited by 38
Application of single-cell RNA sequencing on human testicular samples: a comprehensive review
Dong, F., Ping, P., Ma, Y., & Chen, X. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.82191 · Cited by 39
“Mouse phenotype information from the MGI database Hikmet et al. 2020 Sweden Normal 1.”
BackgroundMethodInfluentialGlycosylation in SARS-CoV-2 variants: A path to infection and recovery
Aloor, A., Aradhya, R., Venugopal, P., Nair, B. G., & Suravajhala, R. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115335 · Cited by 39
“ANG II will specifically bind to ACE2 and convert angiotensin II, a multipurpose peptide hormone, to small peptides, angiotensin 1–7, that regulate the functions of cells [93].”
Exploring the potential of foodborne transmission of respiratory viruses
O'Brien, B., Goodridge, L. D., Ronholm, J., & Nasheri, N. (2020) · Food Microbiology · doi:10.1016/j.fm.2020.103709 · Cited by 39
Ng, J., Sun, A. X., Je, H. S., & Tan, E. (2021) · The Neuroscientist · doi:10.1177/10738584211015136 · Cited by 38
ACE2 function in the pancreatic islet: Implications for relationship between SARS‐CoV‐2 and diabetes
Memon, B., & Abdelalim, E. M. (2021) · Acta Physiologica · doi:10.1111/apha.13733 · Cited by 38
Farrell, A. G., Dadonaite, B., Greaney, A. J., Eguia, R. T., Loes, A. N., Franko, N., Logue, J. K., Carreño, J. M., Abbad, A., Chu, H. Y., et al. (2022) · Viruses · doi:10.3390/v14092061 · Cited by 37
Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry
Wang, P., Zhou, R., Zhou, R., Li, W., Weerasinghe, J., Chen, S., Rehm, B. H. A., Zhao, L., Frentiu, F. D., Zhang, Z., et al. (2022) · Theranostics · doi:10.7150/thno.70098 · Cited by 39
“3 tissues with high exposure risk such as nose, throat and lung ([43]), may represent an emerging and promising approach against the outbreak of viral diseases relying on this receptor for host entry ([44]).”
BackgroundACE2 partially dictates the host range and tropism of SARS-CoV-2
Gao, S., & Zhang, L. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.032 · Cited by 37
“However, it can be concluded that the expression level of ACE2 in airway especially in lung is relatively low, considering the consistent and high expression in other organs, such as intestine and kidney [15,60,61].”
Fu, J., Wei, C., He, J., Zhang, L., Zhou, J., Balaji, K. S., Shen, S., Peng, J., Sharma, A., & Fu, J. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.54055 · Cited by 36
“However, from our previous study and other studies, ACE2 expression was very low in human lungs, showing moderate expression in the alveolar macrophages, and a few in the type I alveolar epithelial cells and type II alveolar epithelial cells, but most of the typeIIalveolar epithelial cells were ACE2 negative [39, 42].”
ResultTarnawski, A. S., & Ahluwalia, A. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i3.275 · Cited by 37
Colleluori, G., Graciotti, L., Pesaresi, M., Vincenzo, A. D., Perugini, J., Mercurio, E. D., Caucci, S., Bagnarelli, P., Zingaretti, C. M., Nisoli, E., et al. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01071-w · Cited by 37
“Importantly, despite being the first SARS-CoV-2 targets, olfactory and respiratory epithelial cells express low ACE2 protein levels [38].”
BackgroundMasachessi, G., Castro, G., Cachi, A. M., Marinzalda, M. D. L. Á., Liendo, M., Pisano, M. B., Sicilia, P. E., Ibarra, G., Rojas, R. M., López, L., et al. (2022) · Water Research · doi:10.1016/j.watres.2022.118541 · Cited by 36
SARS‐CoV ‐2 biology and variants: anticipation of viral evolution and what needs to be done
Luo, R., Delaunay, A., Timmis, K. N., & Danchin, A. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15487 · Cited by 40
“In the lung, it is expressed at a low level in some alveolar type 2 cells, and the expression seems to be person-specific (Hikmet et al., 2020; Zou et al., 2020).”
BackgroundComplement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19
Kawakami, E., Saiki, N., Yoneyama, Y., Moriya, C., Maezawa, M., Kawamura, S., Kinebuchi, A., Kono, T., Funata, M., Sakoda, A., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.09.001 · Cited by 36
Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
Brown, E. E. F., Rezaei, R., Jamieson, T. R., Dave, J., Martin, N. T., Singaravelu, R., Crupi, M. J. F., Boulton, S., Tucker, S., Duong, J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052268 · Cited by 36
“Entry of SARS-CoV-2 is mediated by interaction of the viral Spike glycoprotein (S) with its main target receptor angiotensin converting enzyme 2 (ACE2), found on the surface of mammalian cells, primarily in the lower respiratory tract [2].”
BackgroundSoni, S., Jiang, Y., Tesfaigzi, Y., Hornick, J. L., & Çataltepe, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247510 · Cited by 36
“Despite a plethora of studies showing ACE2 mRNA expression in various cell types in the human lung, there is controversy on the distribution and abundance of ACE2 protein expression, which has critical importance in understanding how SARS-CoV2 infection spreads to the lung [18, 19, 21, 23].”
BackgroundResultMutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection
Shukla, N., Roelle, S. M., Suzart, V. G., Bruchez, A. M., & Matreyek, K. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009715 · Cited by 39
“While immunohistochemical data is more relevant[17], this data is largely observational and not well linked to rates of virus entry or infection.”
BackgroundStrohl, W. R., Ku, Z., An, Z., Carroll, S. F., Keyt, B. A., & Strohl, L. M. (2022) · BioDrugs · doi:10.1007/s40259-022-00529-7 · Cited by 36
Vimentin is an important ACE2 co-receptor for SARS-CoV-2 in epithelial cells
Arrindell, J., Atmeh, P. A., Jayet, L., Sérémé, Y., Mège, J., & Desnues, B. (2022) · iScience · doi:10.1016/j.isci.2022.105463 · Cited by 36
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Chappell, M. C. (2023) · Circulation Research · doi:10.1161/circresaha.123.321883 · Cited by 36
Chen, J., Neil, J. A., Tan, J. P., Rudraraju, R., Mohenska, M., Sun, Y., Walters, E., Bediaga, N. G., Sun, G., Zhou, Y., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01182-0 · Cited by 36
Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations
Garduño-Soto, M., Choreño-Parra, J. A., & Cazarin-Barrientos, J. R. (2020) · Archives of Dermatological Research · doi:10.1007/s00403-020-02156-0 · Cited by 39
Enhanced Validation of Antibodies Enables the Discovery of Missing Proteins
Sivertsson, Å., Lindström, E., Oksvold, P., Katona, B., Hikmet, F., Vuu, J., Gustavsson, J., Sjöstedt, E., von Feilitzen, K., Kampf, C., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00486 · Cited by 37
“29,30 There is a widely acknowledged demand to require higher standards by antibody providers, 4 but even a speci fi c antibody may produce false-positive results due to unspeci fi c o ff -target binding if the protocol is not properly optimized, ultimately leaving the responsibility on the individual…”
Self-citationOcañas, S. R., Ansere, V. A., Tooley, K. B., Hadad, N., Chucair‐Elliott, A. J., Stanford, D. R., Rice, S., Wronowski, B., Pham, K. D., Hoffman, J. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02860-0 · Cited by 34
“Ace2 recently gained attention as the entry receptor for the novel SARS-coronavirus 2 (SARSCoV-2) [99].”
BackgroundPark, R., Chidharla, A., Mehta, K. D., Sun, W., Wulff-Burchfield, E. M., & Kasi, A. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100519 · Cited by 34
Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?
Atkinson, M. A., & Powers, A. C. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00087-5 · Cited by 34
Ahsan, N., Rao, R. S. P., Wilson, R. S., Punyamurtula, U., Salvato, F., Petersen, M., Ahmed, M. K., Abid, M. R., Verburgt, J. C., Kihara, D., et al. (2021) · PROTEOMICS · doi:10.1002/pmic.202000279 · Cited by 34
“Previous studies demonstrated substantial differences in protein abundance levels among cell lines and related tissues [5, 69, 70].”
BackgroundPremature ovarian insufficiency secondary to COVID‐19 infection: An original case report
Wilkins, J., & Al‐Inizi, S. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13719 · Cited by 34
Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19
Cárdenas‐Rodríguez, N., Bandala, C., Vanoye–Carlo, A., Ignacio‐Mejía, I., Gómez‐Manzo, S., Cruz, E. Y. H., Pedraza‐Chaverrí, J., Carmona‐Aparicio, L., & Hernández‐Ochoa, B. (2021) · Antioxidants · doi:10.3390/antiox10060971 · Cited by 35
“Virus entry could be from direct blood circulation infecting vascular endothelium, through nasal cells invading the olfactory epithelium along the nerve to the olfactory bulb, or by leukocyte migration across the BBB and neuronal pathways to the Virchow-Robin space surrounding arterioles and venules, and into the lymp…”
BackgroundCOVID-19 and male reproductive system: pathogenic features and possible mechanisms
Zadeh, A. A., & Arab, D. (2021) · Journal of Molecular Histology · doi:10.1007/s10735-021-10003-3 · Cited by 37
Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level
Chouchana, L., Blet, A., Al-Khalaf, M. H., Kafil, T. S., Nair, G. M., Robblee, J. A., Drici, M., Valnet‐Rabier, M., Micallef, J., Salvo, F., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2499 · Cited by 36
“Finally, it has been hypothesized that myocarditis can occur due to direct cell invasion via the spike protein interacting with the angiotensin- converting enzyme 2 (ACE2) widely expressed and prevalent in cardiomyocytes.(43,44) However, in case of COVID- 19 related myocarditis, SARS- CoV- 2 has not been found in card…”
BackgroundDrug repurposing for the treatment of COVID-19
Kato, Y., Nishiyama, K., Nishimura, A., Noda, T., Okabe, K., Kusakabe, T., Kanda, Y., & Nishida, M. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.04.007 · Cited by 35
A single-cell RNA expression map of human coronavirus entry factorsPreprint
Singh, M., Bansal, V., & Feschotte, C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.08.084806 · Cited by 35
ACE2, B0AT1, and SARS-CoV-2 spike protein: Structural and functional implications
Zhang, Y., Yan, R., & Zhou, Q. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102388 · Cited by 34
Naidu, A. S., Wang, C., Rao, P., Mancini, F., Clemens, R., Wirakartakusumah, A., Chiu, H., Yen, C., Porretta, S., Mathai, I., et al. (2024) · npj Science of Food · doi:10.1038/s41538-024-00261-2 · Cited by 37
Gilham, D., Smith, A. L., Fu, L., Moore, D. Y., Muralidharan, A., Reid, S. P., Stotz, S. C., Johansson, J. O., Sweeney, M., Wong, N. C. W., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9040437 · Cited by 32
“As ACE2 is expressed outside of the lung in tissues also susceptible to SARS-CoV-2 infection [33,34], we assessed ACE2 gene expression in extrapulmonary cells.”
BackgroundCOVID-19 and its effects on the digestive system
Cao, T., Zhang, G., Pellegrini, E., Zhao, Q., Li, J., Luo, L., & Pan, H. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i24.3502 · Cited by 33
Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
Zhu, Q., Xu, Y., Wang, T., & Xie, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1053437 · Cited by 34
“For instance, the expression of ACE2 was limited in the respiratory tract which were favored by SARS-CoV-2 (10).”
BackgroundCan ACE2 expression explain SARS‐CoV‐2 infection of the respiratory epithelia in COVID‐19?
Nawijn, M. C., & Timens, W. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209841 · Cited by 31
“In their recent study, Hikmet et al (2020) present a much-needed updated systematic evaluation of ACE2 expression in a large range of tissues, at the protein as well as the RNA level, confirming the expression in a number of epithelial barrier tissues.”
Angiotensin-(1-7) and Mas receptor in the brain
Mikusic, N. L. R., Pineda, A. M., & Gironacci, M. M. (2021) · Exploration of Medicine · doi:10.37349/emed.2021.00046 · Cited by 35
“A large-scale immunohistochemical analysis of ACE2 expression levels using antibodies validated according to criteria established by the International Working Group for Antibody Validation showed that human brain ACE2 protein expression was below detection limits [67].”
MethodKim, E., Attia, Z., Woodfint, R. M., Zeng, C., Kim, S. H., Steiner, H. E., Shukla, R. K., Liyanage, N. P. M., Ghimire, S., Lǐ, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102435118 · Cited by 31
COVID-19: risk factors for severe cases of the Delta variant
Hu, K., Liu, L., Liang, Y., Shao, X., Hu, Z., Luo, H., & Lei, M. (2021) · Aging · doi:10.18632/aging.203655 · Cited by 35
“The SARS-CoV-2 infection has been observed in small intestinal organoids [14, 15].”
BackgroundRommasi, F., Nasiri, M. J., & Mirsaeidi, M. S. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04325-9 · Cited by 32
“In addition to the lungs, ACE2 is present on the cell membrane of other tissues such as the heart, kidneys, testes, and intestines, enabling SARS-CoV-2 to infect these organs [8, 9].”
BackgroundProtein Expression Profile of ACE2 in the Normal and COVID-19-Affected Human Brain
Lindskog, C., Méar, L., Virhammar, J., Fällmar, D., Kumlien, E., Hesselager, G., Casar‐Borota, O., & Rostami, E. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00184 · Cited by 33
Self-citationValyaeva, A. A., Zharikova, A. A., & Sheval, E. V. (2022) · Cell Biology International · doi:10.1002/cbin.11928 · Cited by 32
“ACE2 was detected by immunohistochemistry in the cornea and conjunctiva of the eye (Hikmet et al., 2020).”
BackgroundScurati, R., Papini, N., Giussani, P., Alberti, G., & Tringali, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012311 · Cited by 34
“ACE2 is expressed by a wide-ranging repertoire of cells, including nasal ciliated and upper bronchial cells, type II alveolar cells in lungs, small intestine and colon enterocytes, gallbladder, testis, kidney, thyroid, heart, and vascular cells [6].”
BackgroundTherapeutic modalities and novel approaches in regenerative medicine for COVID-19
Ramezankhani, R., Solhi, R., Memarnejadian, A., Nami, F., Hashemian, S. M. R., Tricot, T., Vosough, M., & Verfaillie, C. M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106208 · Cited by 31
Not so sweet and simple: impacts of SARS-CoV-2 on the β cell
Ibrahim, S., Monaco, G. S. F., & Sims, E. K. (2021) · Islets · doi:10.1080/19382014.2021.1909970 · Cited by 32
“(2020) Mol Syst Biol.(39) ● Sample size: n = 10 formalin-fixed paraffin-embedded (FFPE) pancreatic”
BackgroundResultInfluentialPlasma ACE2 species are differentially altered in COVID‐19 patients
García‐Ayllón, M., Moreno, Ó., García‐Arriaza, J., Ramos‐Rincón, J., Cortés‐Gómez, M., Brinkmalm, G., Andrés, M., León‐Ramírez, J., Boix, V., Gil, J., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100051r · Cited by 31
Xie, L., Zhang, Z., Wang, Q., Chen, Y., Lu, D., & Wu, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.772865 · Cited by 33
“Expression levels of ACE2 in the lungs are very low, and they are only expressed in a small part of lung epithelial cells (36), moreover, they may even be undetectable in endothelial cells of lung tissues.”
BackgroundLung Organoids as Model to Study SARS-CoV-2 Infection
Peng, L., Gao, L., Wu, X., Fan, Y., Liu, M., Chen, J., Song, J., Kong, J., Dong, Y., Li, B., et al. (2022) · Cells · doi:10.3390/cells11172758 · Cited by 31
“SARS-CoV-2 is more likely to infect the upper respiratory tract than the distal lung [66,67].”
BackgroundEndometriosis and COVID-19: A Systematic Review and Meta-Analysis
Kabani, Z., Ramos‐Niño, M. E., & Ramdass, P. V. A. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112951 · Cited by 30
“Nonetheless, their study suggests that low expression of ACE2 and TMPRSS2 in endometrial cells does not imply that other mechanisms are not involved in infectivity [44].”
BackgroundInfluentialZhu, H., Zhang, H., Zhou, N., Ding, J., Jiang, J., Liu, T., Liu, Z., Wang, F., Zhang, Q., Zhang, Z., et al. (2021) · Advanced Science · doi:10.1002/advs.202100965 · Cited by 32
The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?
Brooks, E. F., & Bhatt, A. S. (2021) · Molecular Case Studies · doi:10.1101/mcs.a006031 · Cited by 32
“Angiotensin-converting enzyme 2 (ACE2), the cellular receptor for SARS-CoV-2, is expressed by nonrespiratory tissues, including the heart and liver, with highest levels present in the small intestine, testes, kidney, and gallbladder (Hamming et al. 2004; Hikmet et al. 2020; Hoffmann et al. 2020; Li et al. 2020).”
BackgroundInfluentialThe relationship between SARS-CoV-2 infection and type 1 diabetes mellitus
Debuysschere, C., Nekoua, M. P., Alidjinou, E. K., & Hober, D. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01004-9 · Cited by 32
Renin Angiotensin System, COVID-19 and Male Fertility: Any Risk for Conceiving?
Pascolo, L., Zito, G., Zupin, L., Luppi, S., Giolo, E., Martinelli, M., Rocco, D. D., Crovella, S., & Ricci, G. (2020) · Microorganisms · doi:10.3390/microorganisms8101492 · Cited by 32
“Indeed, the role of ACE2 in viral infection and correlation to clinical condition is still to be unraveled [70].”
BackgroundResultThe calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic
The ESHRE COVID-19 Working Group, Gianaroli, L., Ata, B., Lundin, K., Rautakallio-Hokkanen, S., Tapanainen, J. S., Vermeulen, N., Veiga, A., & Mocanu, E. V. (2020) · Human Reproduction · doi:10.1093/humrep/deaa285 · Cited by 30
“The ACE2 receptor is present in many human tissues, including testis, ovary, vagina and uterus, although, at the moment, there is no clear evidence of its presence in gametes (Hikmet et al., 2020; Li et al., 2020b).”
BackgroundSARS-CoV-2 Infection and Pancreatic β Cell Failure
Mine, K., Nagafuchi, S., Mori, H., Takahashi, H., & Anzai, K. (2021) · Biology · doi:10.3390/biology11010022 · Cited by 33
“These studies also showed that ACE2 protein was undetectable in β cells, but was found in exocrine capillaries, pericytes, the microvasculature, and in islet ducts in COVID-19 and non-COVID-19 subjects [80,82,83,87].”
ResultLRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
(2023) · doi:10.1371/journal.pbio.3001959 · Cited by 28
“The overlap with cell types expressing ACE2 was relatively weak, although as previously reported, these methods only detect ACE2 at very low levels and incompletely [11,41,42].”
Ravichandran, B., Grimm, D. G., Krüger, M., Kopp, S., Infanger, M., & Wehland, M. (2021) · Physiological Reports · doi:10.14814/phy2.14800 · Cited by 32
“In humans it is mainly expressed in enterocytes, renal tubules, gallbladder, cardiomyocytes, male reproductive cells, placental trophoblasts, ductal cells, eye, and vasculature (Hikmet et al., 2020), and its activation leads to various effects such as antiarrhythmic effects and vasodilation through the release of nitr…”
BackgroundHilpert, K., & Mikut, R. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.732838 · Cited by 30
3D Human Organoids: The Next “Viral” Model for the Molecular Basis of Infectious Diseases
Chia, S. P. S., Kong, S. L. Y., Pang, J. K. S., & Soh, B.-S. (2022) · Biomedicines · doi:10.3390/biomedicines10071541 · Cited by 29
Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells
Aicher, S., Streicher, F., Chazal, M., Planas, D., Luo, D., Buchrieser, J., Němcová, M., Seidlova, V., Zukal, J., Cobo, J. S., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00608-22 · Cited by 28
“ACE2 is also highly expressed in human kidney (56).”
BackgroundEndocrine and metabolic complications of COVID-19: lessons learned and future prospects
Esmaeilzadeh, A., Elahi, R., Siahmansouri, A., Maleki, A. J., & Moradi, A. (2022) · Journal of Molecular Endocrinology · doi:10.1530/jme-22-0036 · Cited by 32
Suzuki, S., Geri, J. B., Knutson, S. D., Bell‐Temin, H., Tamura, T., Fernández, D. F., Lovett, G. H., Till, N. A., Heller, B. L., Guo, J., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c06806 · Cited by 28
Daou, M., Kannout, H., Khalili, M., Almarei, M., Alhashami, M., Alhalwachi, Z., Alshamsi, F. Y., Bataineh, M. T. A., Kayasseh, M. A., AlKhajeh, A. S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274961 · Cited by 28
Cell-intrinsic differences between human airway epithelial cells from children and adults
Maughan, E. F., Hynds, R. E., Pennycuick, A., Nigro, E., Gowers, K. H. C., Denais, C., Gómez‐López, S., Lazarus, K. A., Orr, J. C., Pearce, D. R., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105409 · Cited by 30
Vaibhav, V., Nishad, S., Dongare, D. B., Tripathi, A. C. P., Tripathi, T., & Tripathi, P. (2024) · Health Sciences Review · doi:10.1016/j.hsr.2024.100201 · Cited by 40
SARS-CoV-2 cell entry and targeted antiviral development
Chen, Z., Du, R., Achi, J. G., Rong, L., & Cui, Q. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.007 · Cited by 28
“For example, ACE2 expression in human lung and respiratory tract is extremely low and limited in the epithelium 25,28 e 30 , however, it’s well studied that SARS-CoV-2 preferentially infects cells of the respiratory tract 31 , and SARS-CoV-2 can successfully infect human H522 lung adenocarcinoma…”
SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection
Trbojević‐Akmačić, I., Petrović, T., & Lauc, G. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-10021-z · Cited by 27
“Although ACE2 is broadly expressed in different mammalian tissues [15, 16] and has been recognized as the main host cell receptor for SARS-CoV-2 cell entry [17–19], some studies have reported low expression of ACE2 in the respiratory system [15, 20, 21] indicating that S glycoprotein could interact with other receptor…”
BackgroundWilliams, T. L., Strachan, G., Macrae, R. G. C., Kuc, R. E., Nyimanu, D., Paterson, A., Sinha, S., Maguire, J. J., & Davenport, A. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-03731-9 · Cited by 27
miRNAs: The Key Regulator of COVID-19 Disease
Hardin, L. T., & Xiao, N. (2022) · International Journal of Cell Biology · doi:10.1155/2022/1645366 · Cited by 27
“ACE2 is expressed inmultiple human tissues, with the highest expression in the gastrointestinal tract, kidney, testis, and heart [50].”
BackgroundSARS-CoV-2 infection and its effects on the endocrine system
Steenblock, C., Toepfner, N., Beuschlein, F., Perakakis, N., Anjana, R. M., Mohan, V., Mahapatra, N. R., & Bornstein, S. R. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101761 · Cited by 27
COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations
Shu, H., Zheng, W., Li, N., Zhang, Z., Ceesay, B. M., Peng, Y., Zhou, N., & Wang, D. W. (2023) · Aging and Disease · doi:10.14336/ad.2023.0314 · Cited by 29
“In May 2020, Hikmet et al. determined the expression of ACE2 in cardiomyocytes based on immunohistochemical analyses [84].”
BackgroundDong, F., Li, H., Liu, L., Yao, L., Wang, J., Xiang, D., Ma, J., Zhang, G., Zhang, S., Li, J., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.81498 · Cited by 27
Risks of digestive diseases in long COVID: evidence from a population-based cohort study
Ma, Y., Zhang, L., Wei, R., Dai, W., Zeng, R., Luo, D., Jiang, R., Wu, H., Zhuo, Z., Yang, Q., et al. (2024) · BMC Medicine · doi:10.1186/s12916-023-03236-4 · Cited by 29
Zhang, Z., Guo, L., Lü, X., Zhang, C., Xianfeng, W. A. N. G., Huang, L., Ma, C. Y., Liang, H., Shao, J., Zeng, L., et al. (2020) · Theranostics · doi:10.2139/ssrn.3602441 · Cited by 26
SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis
Panigrahi, S., Goswami, T., Ferrari, B., Antonelli, C. J., Bazdar, D. A., Gilmore, H., Freeman, M. L., Lederman, M. M., & Sieg, S. F. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00735-21 · Cited by 26
Metadata
- Authors
- Hikmet, F., Méar, L., Edvinsson, Å., Micke, P., Uhlén, M., & Lindskog, C.
- Affiliations
- Uppsala University (SE)
- Science for Life Laboratory (SE)
- Corresponding author
- Lindskog, Cecilia
- Venue
- Molecular Systems Biology
- Published
- 2020-07-01
- Volume
- 16
- Issue
- 7
- Pages
- e9610-e9610
- ISSN
- 1744-4292 (ISSN-L)
- PMC
- PMC7383091
- OpenAlex
- W3044069820
- Cited by
- 1,016
- References
- 67
- Citations by year
- 2026: 31 · 2025: 78 · 2024: 123 · 2023: 165 · 2022: 214 · 2021: 275 · 2020: 130
- FWCI
- 25.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 25 d)
- Locations
- Molecular Systems Biology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Cancerfonden
- Knut and Alice Wallenberg Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- ACE2, SARS-CoV-2, COVID-19 pandemic, host cell entry, protein expression patterns, human tissue, cell type-specific gene expression, enterocytes, renal tubules, cardiomyocytes, placental trophoblast, respiratory system, host susceptibility
- MeSH terms
- Betacoronavirus, Host Microbial Interactions, RNA-Seq, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Blood Vessels, Conjunctiva, Female, Gallbladder, Humans, Immunohistochemistry, Kidney Tubules, Proximal, Peptidyl-Dipeptidase A, Male, Organ Specificity, Placenta, Pregnancy, Respiratory System, Mass Spectrometry, Testis, Enterocytes, Myocytes, Cardiac, Single-Cell Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.